We are live on ! Find out more
SP

Sarasin & Partners Portfolio holdings

AUM $8.54B
1-Year Est. Return 9.6%
This Fund
S&P 500
This Quarter Est. Return
+7.93%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$9.58B
AUM Growth
+$1.1B
Cap. Flow
+$471M
Cap. Flow %
4.92%
Top 10 Hldgs %
35.78%
Holding
107
New
4
Increased
62
Reduced
24
Closed

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$116M
2
HDB icon
HDFC Bank
HDB
+$87.3M
3
MSFT icon
Microsoft
MSFT
+$70M
4
ILMN icon
Illumina
ILMN
+$43.3M
5
CL icon
Colgate-Palmolive
CL
+$41.9M

Top Sells

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$94.1M
2
ECL icon
Ecolab
ECL
+$61M
3
DE icon
Deere & Co
DE
+$46.1M
4
MIDD icon
Middleby
MIDD
+$39.8M
5
OTIS icon
Otis Worldwide
OTIS
+$23.7M

Sector Composition

Rank Sector Weight
1 Financials 17.34%
2 Technology 16.87%
3 Industrials 13.85%
4 Consumer Discretionary 12.69%
5 Healthcare 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMX icon
51
Fomento Económico Mexicano
FMX
$43.6B
$32.5M 0.34%
384,141
+16,429
+4% +$1.35M
LLY icon
52
Eli Lilly
LLY
$1.02T
$29.3M 0.31%
127,754
+5,481
+4% +$1.1M
CSCO icon
53
Cisco
CSCO
$457B
$26.9M 0.28%
508,266
-9,412
-2% -$495K
MSCI icon
54
MSCI
MSCI
$41.6B
$26.8M 0.28%
50,343
+2,139
+4% +$1.02M
EW icon
55
Edwards Lifesciences
EW
$49.6B
$26.4M 0.28%
254,535
+52,386
+26% +$4.94M
NATI
56
DELISTED
National Instruments Corp
NATI
$25.5M 0.27%
+604,279
New +$25.4M
OC icon
57
Owens Corning
OC
$11.2B
$24.4M 0.25%
249,082
+10,681
+4% +$1.07M
PFE icon
58
Pfizer
PFE
$143B
$23.7M 0.25%
605,621
-1,549
-0.3% -$60.2K
WY icon
59
Weyerhaeuser
WY
$18B
$20M 0.21%
582,477
-134,319
-19% -$4.98M
AGCO icon
60
AGCO
AGCO
$7.4B
$16.3M 0.17%
125,000
+5,000
+4% +$704K
IFF icon
61
International Flavors & Fragrances
IFF
$20.2B
$14.9M 0.16%
100,000
MPT
62
Medical Properties Trust
MPT
$2.77B
$13.5M 0.14%
+669,537
New +$14.3M
COLD icon
63
Americold
COLD
$4.02B
$13.2M 0.14%
350,000
-25,000
-7% -$968K
ARE icon
64
Alexandria Real Estate Equities
ARE
$8.97B
$11.6M 0.12%
63,717
-577
-0.9% -$103K
CPT icon
65
Camden Property Trust
CPT
$11B
$10.7M 0.11%
80,991
MAA icon
66
Mid-America Apartment Communities
MAA
$15.4B
$9.13M 0.1%
54,212
CF icon
67
CF Industries
CF
$19.2B
$9M 0.09%
175,000
LSI
68
DELISTED
Life Storage, Inc.
LSI
$8.68M 0.09%
80,894
ZBRA icon
69
Zebra Technologies
ZBRA
$14B
$8.44M 0.09%
15,942
-188,796
-92% -$94.1M
BXP icon
70
Boston Properties
BXP
$11.2B
$8.14M 0.08%
70,998
DOC icon
71
Healthpeak Properties
DOC
$15.1B
$8.04M 0.08%
241,644
GLD icon
72
SPDR Gold Trust
GLD
$131B
$7.52M 0.08%
45,405
+3,863
+9% +$656K
SBRA icon
73
Sabra Healthcare REIT
SBRA
$5.34B
$7.19M 0.08%
395,272
+102,683
+35% +$1.83M
AGG icon
74
iShares Core US Aggregate Bond ETF
AGG
$137B
$7.11M 0.07%
61,613
-2,020
-3% -$231K
MKC icon
75
McCormick & Company Non-Voting
MKC
$13.7B
$7.07M 0.07%
+80,000
New +$7.13M

Similar funds

Sarasin & Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Sarasin & Partners held 107 positions worth $9.58B, up 13% from $8.48B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sarasin & Partners deployed $471M of net new capital in Q2 2021, opening 4 new positions and adding to 62 existing holdings. Its largest new stake was National Instruments Corp: 604,279 shares worth $25.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Zebra Technologies, an estimated $94.1M trimmed.

  • Sarasin & Partners's largest Q2 2021 buy was National Instruments Corp: 604,279 shares worth $25.5M.
  • Sarasin & Partners added most to Costco in Q2 2021, an estimated $116M increase.
  • Sarasin & Partners's biggest Q2 2021 reduction was Zebra Technologies, cutting an estimated $94.1M.
  • Sarasin & Partners's ten largest holdings make up 36% of its $9.58B portfolio in Q2 2021.
  • Sarasin & Partners opened 4 new positions and closed 0 in Q2 2021.
  • Sarasin & Partners's portfolio value rose 13% quarter-over-quarter to $9.58B.

Based on Sarasin & Partners's 13F filing for Q2 2021, filed 13 Jul 2021.